Louisville Metabolic and Atherosclerosis Research Center — Louisville, Kentucky

Louisville Metabolic and Atherosclerosis Research Center is a clinical research site located in Louisville, Kentucky, United States 40213.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Louisville Metabolic and Atherosclerosis Research Center has participated in 11 clinical trials with 3 currently active.

Therapeutic areas: Obesity, Overweight, Type 2 Diabetes Mellitus.

Sponsors: Amgen, Pfizer, Arisaph Pharmaceuticals Inc.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Louisville Metabolic and Atherosclerosis Research Center?

Louisville Metabolic and Atherosclerosis Research Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Louisville Metabolic and Atherosclerosis Research Center conducted?

Louisville Metabolic and Atherosclerosis Research Center has 11 clinical trials on record, with 3 currently active. Their work covers Obesity, Overweight, Type 2 Diabetes Mellitus.

Is Louisville Metabolic and Atherosclerosis Research Center accredited by Crixeo Health?

Yes — Louisville Metabolic and Atherosclerosis Research Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Louisville Metabolic and Atherosclerosis Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.